Industry-sponsored pharmaceutical trials and research ethics boards: Are they cloaked in too much secrecy?

CMAJ. Canadian Medical Association Journal

Volumn 166, Issue 10, 2002, Pages 1279-1280

  Ferris, Lorraine E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONFIDENTIALITY; DECISION MAKING; DRUG INDUSTRY; HUMAN; HUMAN RIGHTS; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; MEDICAL RESEARCH; MEDICOLEGAL ASPECT; NOTE; PATIENT INFORMATION; PRESCRIPTION; QUALITY CONTROL; SAFETY;

EID: 0036091748     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Ethics behind closed doors: Do research ethics committees need secrecy?
2. A case study in adolescent participation in clinical research: Eleven clinical sites, one common protocol, and eleven IRBs
3. Variability among institutional review boards' decisions within the context of a multicenter trial
4. Health researchers' views of ethics committee functioning in New Zealand
5. Local research ethics committee approval for a national study in Scotland
6. The new system of review by multicentre research ethics committees: Prospective study
7. Responses of local research ethics committees to a study with approval from a multicentre research ethics committee
8. Multicentre research ethics committees: Has the cure been worse than the disease?
9. Meeting the challenges facing research ethics committees: Some practical suggestions